JUL 11, 2018 02:13 AM PDT

'Acetazolamide' Used To Treat Altitude Sickness, Slows Down the Development of Glioblastoma

WRITTEN BY: Nouran Amin

 

 

Acetazolamide, which is sold under the trade name Diamox and used to treat altitude sickness, is considered inexpensive to manufacture and easy to administer.

"I take it myself, whenever I go to the Rocky Mountains," explains study director Bahktiar Yamini, MD, a professor of neurosurgery at the University of Chicago Medicine. Although acetazolamide has minimal side effects, users report "a metallic taste when drinking something carbonated."

Acetazolamide is a studied to be a carbonic anhydrase inhibitor drug that can restore another drug's ability to eradicate tumor cells.

More specifically, acetazolamide when added to a drug called temozolomide (TMZ), it was seen to slow down the progression of glioblastoma in mouse models.

Acetazolamide enables TMZ to damage the DNA present in tumor cells in order to inhibit its growth.

Researchers discovered that glioblastoma patients with increased levels of a protein called BCL-3 (B cell CLL/lymphoma 3) were unresponsive to the effects exerted by the chemotherapeutic drug, TMZ. In particular, BCL-3 protects cancer cells from TMZ damage by activating a protective enzyme known as carbonic anhydrase II.

"We tested this combination treatment strategy in several animal models," Yamini said. “It cured some of them. Others had a 30 to 40 percent increase in survival time.”

Furthermore, the researchers examined BCL-3 levels from earlier human studies and found that patients with lower levels of BCL-3 who were treated with TMZ had a higher survival rate than patients who had high levels of this biomarker.

"An important feature of predictors like BCL-3 is that they are informative," the authors note. "They can identify pathways to improve treatment response."

By studying those pathways, carbonic anhydrase inhibitors were identified, such as acetazolamide, as a way to decrease the resistance to temozolomide.

"Our data," they note, demonstrate that it is the "induction of CAII by TMZ that is important in modulating response to therapy."

Confirming the use of BCL-3 to predict which patients will benefit from the use of temozolomide will require validation through clinical trials.

Additionally, the authors believe that repurposing the use of acetazolamide along with temozolamide might be particularly effective for patients with tumors that have high BCL-3 expression.

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 20, 2019
Cell & Molecular Biology
SEP 20, 2019
Progress on a Potential Drug for Inflammatory Disease
A team of researchers is trying to develop a treatment for chronic inflammatory disorders by inhibiting a complex called the NLRP3 inflammasome....
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
HIV Therapeutics Places Risk of Neural Tube Defects
In a study published in the New England Journal of Medicine, women taking an HIV therapeutic drug containing dolutegravir have a higher risk of giving birt...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Promising Drug Encourages Survival in Pancreatic Cancer
Building on almost 20 years of research, a phase 1 clinical trial drug for pancreatic cancer, named ‘AZD1775’, shows promising initial results ...
SEP 20, 2019
Cancer
SEP 20, 2019
Cancer drugs don't work the way we thought
New research recently published in the journal Science Translational Medicine surprises the oncological community with findings that a protein previously t...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
A Diabetic Drug that Promotes Brain Repair...But it Only Works in Females
Gender discrimination in research has long stopped serious advancements. In neuroscience, scientists believed that male brains are straightforward and do n...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Does TruBrain Really Work?
TruBrain is a mix of different substances claimed to help people increase verbal fluency, avoid distractions, and boost their mental output. Created by a t...
Loading Comments...